Phase 1 Trial Will Test Oral PTC518 Candidate Therapy; First Results Due Early 2021
News
A Phase 1 trial will evaluate PTC Therapeutic’s PTC518, its investigational therapy for Huntington’s disease, in healthy volunteers, the company announced. The trial’s first results are expected in the first half ... Read more